Skip to Main Content

Paper Details

Real-world use of nirmatrelvir-ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study.
Lancet Infect Dis
54
2023
Author NameAffiliation
Neil R AggarwalUniversity of Colorado School of Medicine
Tellen D BennettUniversity of Colorado School of Medicine, USA Colorado Clinical and Translational Sciences Institute, University of Colorado Anschutz Medical Campus
Seth RussellUniversity of Colorado School of Medicine, USA Colorado Clinical and Translational Sciences Institute, University of Colorado Anschutz Medical Campus
Adit A GindeUniversity of Colorado School of Medicine
  • 1 - 4

Datasets